Yuexin Liu

64.1k citations
56 papers · 1.5k indexed · 1 hit paper · h-index 16

Yuexin Liu

51 papers receiving 1.5k citations

Hit Papers

Integrated Analysis of TP53 Gene and Pathway Alterations ...4212019202620212023100200300400

Peers

Yuexin Liu
Comparison fields: 5 of 120
  • Cancer Research 659
  • Obstetrics and Gynecology 116
  • Oncology 401
  • Molecular Biology 872
  • Genetics 114
Replace Gloria Peiró with:
Gloria Peiró Spain
Wenfeng Cao China
Neyaz Alam India
S. John Weroha United States
Lin Guo China
Yutaka Hatanaka Japan
Lisha Qi China
Daniele Fanale Italy
Melanie A. Krook United States
Yuexin Liu relative to Gloria Peiró Spain Gloria Peiró's profile →
Citations per field
00.5×1.5×2.2×
Gloria Peiró · 1×
Citations per year

Countries citing papers authored by Yuexin Liu

Since Specialization
Citations

This map shows the geographic impact of Yuexin Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuexin Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuexin Liu more than expected).

Fields of papers citing papers by Yuexin Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuexin Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuexin Liu. The network helps show where Yuexin Liu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuexin Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuexin Liu Line = papers co-authored together Yuexin Liu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20251
4 20252
5 20243
6 20240
7 202415
8 20240
9 20240
10 20235
11 20231
12 202211
13 202112
14 20192
15 201912
16
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlasbreakdown →
2019421
17 201811
18 201688
19 201619
20 201214

About Yuexin Liu

Yuexin Liu is a scholar working on Cancer Research, Biological Psychiatry and Oncology, having authored 56 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (6 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), RNA modifications and cancer (5 papers), Ovarian cancer diagnosis and treatment (4 papers) and Circular RNAs in diseases (4 papers). The work is most often cited by research in Cancer Research (659 citations), Obstetrics and Gynecology (116 citations) and Oncology (401 citations). Yuexin Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include John N. Weinstein, Limei Hu, Thierry Soussi, Teng‐Kuei Hsu, Olivier Lichtarge, Xubin Li, Anil Korkut, Özgün Babur, Rehan Akbani and Maria Cardenas. Their work appears in journals such as Oncotarget, Cancer, The Journal of Pathology, Cancer Research and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026